Literature DB >> 12052275

New scavenger receptors and their functions in atherogenesis.

Noriaki Kume1, Toru Kita.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12052275     DOI: 10.1007/s11883-002-0001-y

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  57 in total

1.  Identification of soluble forms of lectin-like oxidized LDL receptor-1.

Authors:  T Murase; N Kume; H Kataoka; M Minami; T Sawamura; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

2.  Inhibition of LOX-1 by statins may relate to upregulation of eNOS.

Authors:  J L Mehta; D Y Li; H J Chen; J Joseph; F Romeo
Journal:  Biochem Biophys Res Commun       Date:  2001-12-14       Impact factor: 3.575

3.  Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells.

Authors:  H Morawietz; N Duerrschmidt; B Niemann; J Galle; T Sawamura; J Holtz
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

4.  Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein.

Authors:  M P Ramprasad; V Terpstra; N Kondratenko; O Quehenberger; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria.

Authors:  T Shimaoka; N Kume; M Minami; K Hayashida; T Sawamura; T Kita; S Yonehara
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

6.  Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions.

Authors:  M Minami; N Kume; T Shimaoka; H Kataoka; K Hayashida; Y Akiyama; I Nagata; K Ando; M Nobuyoshi; M Hanyuu; M Komeda; S Yonehara; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-11       Impact factor: 8.311

7.  Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells.

Authors:  T Murase; N Kume; R Korenaga; J Ando; T Sawamura; T Masaki; T Kita
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

8.  Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells.

Authors:  N Kume; M A Gimbrone
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein.

Authors:  H Moriwaki; N Kume; T Sawamura; T Aoyama; H Hoshikawa; H Ochi; E Nishi; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-10       Impact factor: 8.311

10.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts.

Authors:  B Björkerud; S Björkerud
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-03       Impact factor: 8.311

View more
  3 in total

1.  Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease.

Authors:  Mehmet Balın; Ahmet Celik; M Ali Kobat
Journal:  Clin Res Cardiol       Date:  2011-11-25       Impact factor: 5.460

2.  Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat; Adil Baydas
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

3.  Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon.

Authors:  Ilker Murat Caglar; Cem Ozde; Ismail Biyik; Fatma Nihan Turhan Caglar; Ibrahim Faruk Akturk; Murat Ugurlucan; Osman Karakaya
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.